Florida, March 05, 2018:

    Attention Deficit Hyperactivity Disorder Therapeutics Market 2018 to 2024

    The Attention Deficit Hyperactivity Disorder Therapeutics market is expected to exceed more than US$ 25 Billion by 2024; Growing at a CAGR of more than 6% in the given forecast period.

    The scope of the report includes a detailed study of global and regional markets for Attention deficit hyperactivity disorder (ADHD) therapeutics market for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market.

    Key players profiled in the report  are as below:

    Eli Lilly and Company

    Novartis AG

     Shire PLC

     Pfizer, Inc

    GlaxoSmithKline PLC

    Mallinckrodt Pharmaceuticals

    Hisamitsu Pharmaceutical Co., Inc

    Impax Laboratories, Inc

    Johnson & Johnson

    UCB S.A

    Purdue Parma L.P

    Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    Browse Full Report @: https://www.marketresearchengine.com/reportdetails/attention-deficit-hyperactivity-disorder-therapeutics-market

    The Attention Deficit Hyperactivity Disorder Therapeutics Market has been segmented as below:  

    By Drug Type Analysis

    •  Non-stimulants

    Atomoxetine
    Bupropion
    Guanfacine
    Clonidine

    •    Stimulants

    Amphetamine
    Methylphenidate
    Dextroamphetamine
    Dexmethylphenidate
    Lisdexamfetamine
    Dimesylate

    By Age Group Analysis

    Pediatric and Adolescent
    Adults

    By Distribution Channel Analysis

    Specialty Clinics
    Hospital Pharmacies
    Retail Pharmacies
    e-Commerce

    By Regional Analysis

    North America
    Europe
    Asia-Pacific
    Rest of the World

    This report provides:
    1) An overview of the global market for attention deficit hyperactivity disorder therapeutics and related technologies.
    2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
    3) Identifications of new market opportunities and targeted promotional plans for attention deficit hyperactivity disorder therapeutics.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    Buy Report from here: https://www.marketresearchengine.com/reportdetails/attention-deficit-hyperactivity-disorder-therapeutics-market

    Table of Contents

    1. Introduction
    2. Research Methodology
    3. Overview
    4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    5. Market Segmentation
    6. Geographical Analysis
    7. Strategic Analysis
    8. Market Leaders’ Analysis
    9. Competitive Landscape
    10. Expert Opinions
    11. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

    11.1 Amedra Pharmaceuticals LLC

    11.2 Eli Lilly and Company

    11.3 Janssen Pharmaceuticals, Inc.

    11.4 Noven Pharmaceuticals, Inc.

    11.5 Novartis Pharmaceuticals Corporation

    11.6 Shire

    11.7 GlaxoSmithKline

    11.8 Celltech Group Ltd.

    11.9 Purdue Pharma L.P.

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

    Source: http://www.financeswire.com/attention-deficit-hyperactivity-disorder-therapeutics-market-share-2018-industry-analysis-growth-and-forecast-to-2024